Invention Grant
- Patent Title: Determination of MAPK-AP-1 pathway activity using unique combination of target genes
-
Application No.: US16145722Application Date: 2018-09-28
-
Publication No.: US11776661B2Publication Date: 2023-10-03
- Inventor: Anja Van De Stolpe , Laurentius Henricus Franciscus Maria Holtzer
- Applicant: InnoSIGN B.V.
- Applicant Address: NL Eindhoven
- Assignee: InnoSIGN B.V.
- Current Assignee: InnoSIGN B.V.
- Current Assignee Address: NL Eindhoven
- Agency: Bond, Schoeneck & King, PLLC
- Priority: EP 209053 2017.12.20
- Main IPC: G16B25/00
- IPC: G16B25/00 ; G06N5/02 ; G16H50/30 ; G16H50/20 ; G06N20/00 ; G16B5/00 ; G16B20/00 ; G16C20/70 ; C12Q1/6886 ; G16H20/10 ; G16H50/50 ; G06N7/01

Abstract:
A bioinformatics process which provides an improved means to detect a MAPK-AP-1 cellular signaling pathway in a subject, such as a human, based on the expression levels of at least three unique target genes of the MAPK-AP-1 cellular signaling pathway measured in a sample. The invention includes an apparatus comprising a digital processor configured to perform such a method, a non-transitory storage medium storing instructions that are executable by a digital processing device to perform such a method, and a computer program comprising program code means for causing a digital processing device to perform such a method. Kits are also provided for measuring expression levels of unique sets of MAPK-AP-1 cellular signaling pathway target genes.
Public/Granted literature
- US20190188359A1 DETERMINATION OF MAPK-AP-1 PATHWAY ACTIVITY USING UNIQUE COMBINATION OF TARGET GENES Public/Granted day:2019-06-20
Information query